Procter & Gamble Stock Performance
Procter & Gamble shares traded at $146.92, per SID market data, reflecting a modest daily gain of 0.09%. Over the trailing one-month period, the stock declined 0.25%, though it posted a 5.31% gain over the past three months, indicating a recent recovery trend. On a twelve-month basis, PG shares rose 2.92%, underperforming broader market indices. The stock currently sits just above its 50-day moving average of $146.86 but remains below its 200-day moving average of $149.82, according to Massive/Polygon technical data. The 14-day RSI reading of 60.6 places the stock in neutral-to-slightly-bullish territory, below overbought thresholds. PG's beta of 0.382 confirms its historically low-volatility profile relative to the broader market. Average daily trading volume stands at approximately 8.54 million shares, supporting consistent liquidity for this $328.9 billion market capitalization consumer defensive name.
Procter & Gamble Valuation Analysis
Procter & Gamble currently trades at a price-to-earnings ratio of 20.46, per SID market data, which is broadly consistent with consumer defensive sector averages but reflects a premium relative to the S&P 500's historical median. The PEG ratio stands at 3.90, according to SEC filings and consensus growth estimates, indicating that the stock's earnings multiple significantly exceeds its projected earnings growth rate. This elevated PEG ratio suggests limited growth relative to the valuation investors are paying. The price-to-book ratio of 6.44 reflects Procter & Gamble's substantial intangible asset base, including its portfolio of globally recognized brands. The company offers a dividend yield of 2.97%, positioning it as an income-generating holding within the consumer staples space. The combination of a moderate P/E ratio with a high PEG ratio highlights the tension between PG's defensive stability and its constrained forward growth trajectory in the current environment.
Smart Money Activity for PG
Procter & Gamble's composite smart money score stands at 52 out of 100, registering a neutral signal, per SID market data. Institutional positioning is notably strong at 25 out of 25, reflecting maximum confidence from large fund managers tracked through 13F institutional filings. Congressional trading activity scored 12.8 out of 25, indicating moderate legislative interest in the stock. Dark pool activity registered at 14.0 out of 25, suggesting average levels of off-exchange institutional block trading. Insider activity, however, scored 0.0 out of 25, the lowest possible reading. According to SEC Form 4 filings, there were 20 insider transactions recorded over the past 90 days, comprising 6 purchases and 14 sales. The sell-to-buy ratio of more than two-to-one among corporate insiders contrasts with the strong institutional conviction, creating a divergence in smart money signals. This insider selling pattern warrants monitoring alongside upcoming quarterly results for context on executive sentiment.
Procter & Gamble Earnings Outlook
Procter & Gamble has demonstrated consistent earnings execution in its most recent reporting periods. In the quarter reported on July 29, 2026, the company posted earnings per share of $1.43, exceeding the consensus estimate of $1.42 by $0.01, according to company earnings reports. The prior quarter, reported on April 24, 2026, showed a stronger beat, with actual EPS of $1.59 surpassing the $1.56 analyst estimate by $0.03. Looking ahead, Wall Street analysts project EPS of $1.42 for the upcoming quarter ending July 28, 2026, and $1.57 for the period ending April 23, 2026, per analyst estimates. The pattern of modest positive surprises reflects PG's disciplined cost management and pricing power across its consumer product portfolio. Both recent beats were narrow in magnitude, consistent with the company's historically low earnings volatility and the mature, predictable nature of its global staples business.
Wall Street Analyst Ratings for PG
Wall Street sentiment on Procter & Gamble has shifted toward a more cautious stance in recent weeks. On August 7, 2026, Argus Research downgraded PG from Buy to Hold, per Wall Street analyst reports, marking a notable reduction in conviction from a historically bullish voice. Similarly, HSBC downgraded the stock from Buy to Hold on July 30, 2026, adding to the trend of moderating expectations. These two downgrades were partially offset by reaffirmations from bullish analysts: Citigroup maintained its Buy rating on July 30, and JP Morgan reiterated its Overweight rating on July 16, according to SID consensus data. Barclays maintained its Equal-Weight rating on July 21, reflecting a neutral posture. The net effect shows 2 downgrades against zero upgrades over the past month, with the remaining 3 actions being maintenance of existing ratings. The emerging pattern suggests growing concern among certain analysts about PG's ability to deliver meaningful upside from current valuation levels.